risperidone has been researched along with Serotonin Syndrome in 16 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Serotonin Syndrome: An adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The first reported case of quetiapine and citalopram-associated serotonin syndrome is discussed with reference to a Medline, Embase, and PsycINFO literature search." | 7.73 | Quetiapine and citalopram: aetiological significances in serotonin syndrome. ( Marlowe, K; Schirgel, D, 2006) |
| "To report 2 cases of serotonin syndrome associated with combined therapy of risperidone and selective serotonin-reuptake inhibitors (SSRIs) in elderly patients." | 7.72 | Combination risperidone and SSRI-induced serotonin syndrome. ( Karki, SD; Masood, GR, 2003) |
| "BACKGROUND Serotonin syndrome is a condition characterized predominantly by neuromuscular symptoms and altered thermoregulation in response to serotonergic overtone." | 5.48 | Delayed Serotonin Syndrome in the Setting of a Mixed Fluoxetine and Serotonin Antagonist Overdose. ( Lin, CM; Little, K; Reynolds, PM, 2018) |
| "Pretreatment with risperidone (0." | 5.32 | Memantine, an NMDA antagonist, prevents the development of hyperthermia in an animal model for serotonin syndrome. ( Kato, S; Nisijima, K; Shioda, K; Takano, K; Yoshino, T, 2004) |
| " The Naranjo probability scale indicated probable causality for NMS due to quetiapine, haloperidol, and risperidone in this patient, whereas the Naranjo scale assigned only possible causality for serotonin syndrome developing with serotonergic agents." | 3.77 | Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool. ( Ariano, RE; Sokoro, AA; Zivot, J, 2011) |
| " The first reported case of quetiapine and citalopram-associated serotonin syndrome is discussed with reference to a Medline, Embase, and PsycINFO literature search." | 3.73 | Quetiapine and citalopram: aetiological significances in serotonin syndrome. ( Marlowe, K; Schirgel, D, 2006) |
| "Serotonin syndrome and neuroleptic malignant syndrome are two drug toxidromes that have often overlapping and confusing clinical pictures." | 2.50 | Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary. ( Ambaliya, A; Dosi, R; Joshi, H; Patell, R, 2014) |
| "BACKGROUND Serotonin syndrome is a condition characterized predominantly by neuromuscular symptoms and altered thermoregulation in response to serotonergic overtone." | 1.48 | Delayed Serotonin Syndrome in the Setting of a Mixed Fluoxetine and Serotonin Antagonist Overdose. ( Lin, CM; Little, K; Reynolds, PM, 2018) |
| "Serotonin syndrome is an iatrogenic disorder that results from serotonergic overactivity." | 1.36 | A perfect storm in the emergency department. ( Wijdicks, EF; Yee, AH, 2010) |
| "Pretreatment with risperidone (0." | 1.32 | Memantine, an NMDA antagonist, prevents the development of hyperthermia in an animal model for serotonin syndrome. ( Kato, S; Nisijima, K; Shioda, K; Takano, K; Yoshino, T, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (56.25) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Prakash, S | 1 |
| Lodha, D | 1 |
| Rawat, KS | 1 |
| Little, K | 1 |
| Lin, CM | 1 |
| Reynolds, PM | 1 |
| Dosi, R | 1 |
| Ambaliya, A | 1 |
| Joshi, H | 1 |
| Patell, R | 1 |
| Yee, AH | 1 |
| Wijdicks, EF | 1 |
| Zand, L | 1 |
| Hoffman, SJ | 1 |
| Nyman, MA | 1 |
| Sokoro, AA | 1 |
| Zivot, J | 1 |
| Ariano, RE | 1 |
| Shioda, K | 2 |
| Nisijima, K | 3 |
| Kasai, M | 1 |
| Yoshino, T | 3 |
| Kato, S | 2 |
| Karki, SD | 1 |
| Masood, GR | 1 |
| Isbister, GK | 1 |
| Takano, K | 1 |
| Marlowe, K | 1 |
| Schirgel, D | 1 |
| Güzelcan, Y | 1 |
| Kleinpenning, AS | 1 |
| Kohen, I | 1 |
| Gordon, ML | 1 |
| Manu, P | 1 |
| Hamilton, S | 1 |
| Malone, K | 1 |
| Ishiguro, T | 1 |
| Gillman, PK | 1 |
1 review available for risperidone and Serotonin Syndrome
| Article | Year |
|---|---|
Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Clonazepam; Diagnosis, Differential; GABA M | 2014 |
15 other studies available for risperidone and Serotonin Syndrome
| Article | Year |
|---|---|
Coexistence of serotonin syndrome and neuroleptic malignant syndrome: does it exist?
Topics: Adult; Antipsychotic Agents; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Risperidone; | 2021 |
Delayed Serotonin Syndrome in the Setting of a Mixed Fluoxetine and Serotonin Antagonist Overdose.
Topics: Benzodiazepines; Bupropion; Cyproheptadine; Dopamine Uptake Inhibitors; Drug Overdose; Fluoxetine; H | 2018 |
A perfect storm in the emergency department.
Topics: Aged; Alzheimer Disease; Citalopram; Drug Therapy, Combination; Female; Humans; Iatrogenic Disease; | 2010 |
74-year-old woman with new-onset myoclonus.
Topics: Aged; Alzheimer Disease; Cyproheptadine; Diagnosis, Differential; Dopamine Antagonists; Dose-Respons | 2010 |
Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
Topics: Antipsychotic Agents; Catecholamines; Diagnosis, Differential; Dibenzothiazepines; Dopamine; Female; | 2011 |
Risperidone attenuates the increase of extracellular nitric oxide and glutamate levels in serotonin syndrome animal models.
Topics: 5-Hydroxytryptophan; Animals; Brain; Clorgyline; Disease Models, Animal; Fluoxetine; Glutamic Acid; | 2012 |
Combination risperidone and SSRI-induced serotonin syndrome.
Topics: Aged; Aged, 80 and over; Drug Interactions; Fatal Outcome; Female; Humans; Male; Risperidone; Select | 2003 |
Comment: combination risperidone and SSRI-induced serotonin syndrome.
Topics: Drug Therapy, Combination; Humans; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin S | 2003 |
Memantine, an NMDA antagonist, prevents the development of hyperthermia in an animal model for serotonin syndrome.
Topics: 5-Hydroxytryptophan; Animals; Body Temperature; Clorgyline; Disease Models, Animal; Dizocilpine Male | 2004 |
Quetiapine and citalopram: aetiological significances in serotonin syndrome.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Antipsychotic Agents; Bipolar Disorder; Citalopram; Dibenzot | 2006 |
[Life-threatening serotonin syndrome following a single dose of a serotonin reuptake inhibitor during maintenance therapy with a monoamine oxidase inhibitor].
Topics: Antidepressive Agents; Drug Interactions; Humans; Monoamine Oxidase Inhibitors; Risperidone; Selecti | 2006 |
Serotonin syndrome in elderly patients treated for psychotic depression with atypical antipsychotics and antidepressants: two case reports.
Topics: Affective Disorders, Psychotic; Aged; Antidepressive Agents; Antipsychotic Agents; Dibenzothiazepine | 2007 |
Serotonin syndrome during treatment with paroxetine and risperidone.
Topics: Affective Disorders, Psychotic; Humans; Male; Middle Aged; Paroxetine; Risperidone; Selective Seroto | 2000 |
Risperidone counteracts lethality in an animal model of the serotonin syndrome.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Body Temperature; Clorgyline; Disease Models, A | 2000 |
Comments on "Serotonin syndrome during treatment with paroxetine and risperidone".
Topics: Humans; Paroxetine; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Ser | 2001 |